Parallel Advisors LLC reduced its stake in Koninklijke Philips (NYSE:PHG – Get Rating) by 41.4% during the first quarter, HoldingsChannel.com reports. The fund owned 1,447 shares of the technology company’s stock after selling 1,022 shares during the quarter. Parallel Advisors LLC’s holdings in Koninklijke Philips were worth $45,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. American Century Companies Inc. increased its holdings in Koninklijke Philips by 2.9% in the 4th quarter. American Century Companies Inc. now owns 2,465,688 shares of the technology company’s stock valued at $90,861,000 after acquiring an additional 69,253 shares during the last quarter. Thompson Siegel & Walmsley LLC bought a new stake in Koninklijke Philips in the 1st quarter valued at $50,119,000. Pendal Group Ltd bought a new stake in Koninklijke Philips in the 1st quarter valued at $41,513,000. Cambiar Investors LLC increased its holdings in Koninklijke Philips by 23.4% in the 4th quarter. Cambiar Investors LLC now owns 1,213,326 shares of the technology company’s stock valued at $44,711,000 after acquiring an additional 230,102 shares during the last quarter. Finally, DE Shaw & Co. Inc. grew its stake in shares of Koninklijke Philips by 513.2% in the 4th quarter. DE Shaw & Co. Inc. now owns 982,883 shares of the technology company’s stock worth $36,219,000 after buying an additional 822,598 shares in the last quarter. 14.84% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on the stock. Credit Suisse Group dropped their price objective on shares of Koninklijke Philips from €32.50 ($32.83) to €31.00 ($31.31) in a research note on Monday, March 28th. Barclays dropped their price objective on shares of Koninklijke Philips from €45.50 ($45.96) to €45.00 ($45.45) and set an “overweight” rating for the company in a research note on Tuesday, July 5th. UBS Group cut shares of Koninklijke Philips from a “neutral” rating to a “sell” rating in a research note on Thursday, June 16th. StockNews.com assumed coverage on shares of Koninklijke Philips in a research note on Thursday, March 31st. They issued a “hold” rating for the company. Finally, JPMorgan Chase & Co. cut shares of Koninklijke Philips from a “neutral” rating to an “underweight” rating and dropped their price objective for the stock from €26.50 ($26.77) to €21.30 ($21.52) in a research note on Wednesday, May 25th . Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Koninklijke Philips presently has an average rating of “Hold” and an average target price of $30.33.
Koninklijke Philips Price Performance
PHG stock opened at $22.14 on Friday. The stock has a market cap of $19.69 billion, a PE ratio of 5.36, a P/E/G ratio of 1.17 and a beta of 0.97. The company has a current ratio of 1.39, a quick ratio of 0.93 and a debt-to-equity ratio of 0.45. Koninklijke Philips has a 12 month low of $20.12 and a 12 month high of $48.72. The company has a 50-day moving average price of $22.76 and a 200 day moving average price of $28.26.
Koninklijke Philips (NYSE:PHG – Get Rating) last released its quarterly earnings data on Monday, April 25th. The technology company reported $0.32 earnings per share (EPS) for the quarter. The company had revenue of $4.29 billion during the quarter. Koninklijke Philips had a net margin of 19.56% and a return on equity of 9.19%. Equities research analysts anticipate that Koninklijke Philips will post 1.7 earnings per share for the current year.
Koninklijke Philips Company Profile
Koninklijke Philips NV operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, including magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology , and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Get Rating).
Receive News & Ratings for Koninklijke Philips Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Koninklijke Philips and related companies with MarketBeat.com’s FREE daily email newsletter.